Cargando…
Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells
Liposomal doxorubicin (L-DOX) is a popular drug formulation for the treatment of several cancer types (e.g., recurrent ovarian cancer, metastatic breast cancer, multiple myeloma, etc.), but poor nuclear internalization has hampered its clinical applicability so far. Therefore, novel drug-delivery na...
Autores principales: | Quagliarini, Erica, Di Santo, Riccardo, Pozzi, Daniela, Tentori, Paolo, Cardarelli, Francesco, Caracciolo, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466571/ https://www.ncbi.nlm.nih.gov/pubmed/32751061 http://dx.doi.org/10.3390/nano10081482 |
Ejemplares similares
-
The influence of protein corona on Graphene Oxide: implications for biomedical theranostics
por: Quagliarini, Erica, et al.
Publicado: (2023) -
Effect of Protein Corona on The Transfection Efficiency of Lipid-Coated Graphene Oxide-Based Cell Transfection Reagents
por: Quagliarini, Erica, et al.
Publicado: (2020) -
Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
por: Di Santo, Riccardo, et al.
Publicado: (2020) -
Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection
por: Caputo, Damiano, et al.
Publicado: (2022) -
The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells
por: Cui, Lishan, et al.
Publicado: (2022)